Ainos Inc. (AIMD)
| Bid | 0.46 |
| Market Cap | 6.89M |
| Revenue (ttm) | 50.75K |
| Net Income (ttm) | -20.15M |
| EPS (ttm) | -2.71 |
| PE Ratio (ttm) | -0.18 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.49 |
| Volume | 136,373 |
| Avg. Volume (20D) | 651,855 |
| Open | 0.54 |
| Previous Close | 0.53 |
| Day's Range | 0.45 - 0.58 |
| 52-Week Range | 0.40 - 3.10 |
| Beta | 1.52 |
About AIMD
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-...
1 month ago · accessnewswire.com
Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025Report highlights greater visibility in AI Nose developments, including robotics, smart manufacturing, elderly care monitoring, and women's health testing SAN DIEGO, CA / ACCESS Newswire / January 21,...
1 month ago · accessnewswire.com
Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price RuleSAN DIEGO, CA / ACCESS Newswire / January 17, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), today announced that it had received written notification (the "Written Notifi...